Group 1 - The core viewpoint of the news is that Haocen Medical's stock has experienced a decline, with a closing price of 2.82 yuan and a market capitalization of 2.369 billion yuan, indicating a challenging market environment for the company [1] - On March 28, Haocen Medical saw a net inflow of 187,600 yuan in main funds, but over the past five days, there was a total outflow of 4.5704 million yuan, suggesting a negative trend in investor sentiment [1] - The company primarily engages in oral medical services and the research, production, and sales of permanent magnet switches and high/low voltage switchgear products, with key offerings including medical oral services, industrial switch products, and credit big data software services [1] Group 2 - For the latest financial performance, Haocen Medical reported a revenue of 635 million yuan for the third quarter of 2024, reflecting a year-on-year increase of 21.27%, while the net profit was 13.4967 million yuan, showing a year-on-year decrease of 17.31%, with a gross profit margin of 47.97% [1] - The company's price-to-earnings (PE) ratio (TTM) is -24.37, and the price-to-book (PB) ratio is 5.29, with a total market value of 2.369 billion yuan, which is significantly lower than the industry average PE of 48.41 and PB of 3.76 [2] - The industry median PE is 43.56 and median PB is 2.84, indicating that Haocen Medical is underperforming compared to its peers in the healthcare sector [2]
皓宸医疗收盘下跌2.42%,最新市净率5.29,总市值23.69亿元